Encouraging Developments in Cancer Treatments Highlighted at ASCO
The recent ASCO Annual Meeting showcased significant advancements in cancer therapies, with Bristol-Myers Squibb and Pfizer reporting promising results in their respective studies.
Editorial Staff
1 min read
Updated 11 days ago
At the ASCO Annual Meeting held on May 29, 2026, Bristol-Myers Squibb announced positive outcomes in its research on multiple myeloma treatments.
Pfizer also shared encouraging data regarding its lung cancer therapies, contributing to the overall optimism surrounding cancer research at the event.
The ASCO meeting continues to serve as a vital platform for presenting groundbreaking advancements in cancer treatment and research.